Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Sargramostim

Sargramostim

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Sargramostim

67 trials tracked of Sargramostim: 9 in phase 3 or 4 and 2 with published results. The most-cited published study has 137 citations.

67Trials tracked
9Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 8 Phase 2 50 Phase 1 6 Other / NA 2
  1. Phase 4 Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) Completed · 137 cited
  2. Phase 3 A Phase II/III Study of Sargramostim Completed · 3 cited
  3. Phase 3 Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia Completed
  4. Phase 3 GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Completed
  5. Phase 3 Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery Completed
  6. Phase 3 Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Completed
Show 44 more trials
  1. Phase 3 Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma Completed
  2. Phase 3 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia Completed
  3. Phase 3 Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma Completed
  4. Phase 2 Pembrolizumab and GM-CSF in Biliary Cancer Completed
  5. Phase 2 NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders Completed
  6. Phase 2 Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer Completed
  7. Phase 2 Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma Completed
  8. Phase 2 Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer Completed
  9. Phase 2 A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer Completed
  10. Phase 2 Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients Completed
  11. Phase 2 S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma Completed
  12. Phase 2 Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma Completed
  13. Phase 2 Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Completed
  14. Phase 2 Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer Completed
  15. Phase 2 Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors Completed
  16. Phase 2 GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer Completed
  17. Phase 2 PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer Completed
  18. Phase 2 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma Completed
  19. Phase 2 Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Completed
  20. Phase 2 UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma Completed
  21. Phase 2 Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Completed
  22. Phase 2 Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma Completed
  23. Phase 2 Sargramostim Use in COVID-19 to Recover Patient Health Completed
  24. Phase 2 MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia Completed
  25. Phase 2 Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Completed
  26. Phase 2 Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer Completed
  27. Phase 2 GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma Completed
  28. Phase 2 Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma Completed
  29. Phase 2 Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia Completed
  30. Phase 2 Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer Completed
  31. Phase 2 Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence Completed
  32. Phase 2 Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma Completed
  33. Phase 2 153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer Completed
  34. Phase 2 Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer Completed
  35. Phase 2 Vaccine Therapy in Treating Patients With Stage IV Breast Cancer Completed
  36. Phase 2 Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Completed
  37. Phase 2 Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis Completed
  38. Phase 2 Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma Completed
  39. Phase 2 Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma Completed
  40. Phase 2 Inhaled GM-CSF Therapy of Autoimmune PAP Completed
  41. Phase 2 Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma Completed
  42. Phase 2 BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer Completed
  43. Phase 2 Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Completed
  44. Phase 2 Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Completed

Showing the 50 most-cited and recently-updated of 67 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.